Key Takeaways
- ASTS shares currently trade near $85.13, while one bullish analysis suggests a fair value target of $170ārepresenting approximately 50% upside potential
- The company’s BlueBird satellite network has achieved full operational status, while a strategic Rakuten partnership in Japan secured government funding support
- CNBC’s Jim Cramer described ASTS as “a great speculative stock,” expressing confidence the company could achieve profitability in the next 24 months
- Pictet Asset Management expanded its holdings by 146.8% during Q1, though Wall Street consensus remains at “Reduce” with an $85.09 average target
- Company insiders have liquidated more than $280 million in shares over the past quarter, with the CFO selling $4.3 million worth in early June
AST SpaceMobile (ASTS) kicked off Friday’s trading session at $85.13, essentially matching the Street’s consensus price objective of $85.09ācreating an intriguing inflection point for investors evaluating the satellite communications company.
Recent developments have accelerated rapidly. The firm’s BlueBird satellite constellation has reached full operational capability, while a strategic joint venture in Japanāpartnering with Rakuten and benefiting from government financial backingāhas been finalized. These represent significant operational achievements for a company still scaling toward commercial deployment.
In the past week, ASTS shares surged 19.15%. However, the 30-day performance tells a contrasting story, showing a decline of 20.65%. The one-year chart reveals an 86.69% gain, indicating sustained long-term momentum despite recent volatility.
Bull Case Projects $170 Valuation
A prominent bullish analysis establishes a $170 per share fair value estimateāapproximately double the current trading level. This projection assumes AST successfully deploys its BlueBird satellite network, transforms carrier agreements into stable recurring revenues, and ultimately achieves telecom-scale operations. The model applies a 7.108% discount rate.
The company’s financial position provides some support for this optimistic scenario. AST reported approximately $3.5 billion in cash as of March 31, 2026, and management has indicated no plans to pursue additional convertible debt offerings this year. For a capital-intensive infrastructure buildout, this liquidity position offers meaningful runway.
However, valuation concerns remain. The price-to-book ratio stands at 12.2x, substantially above the 1.6x average for the US telecom sector. Even compared to direct competitors at 12.6x, the premium appears stretched for a company still generating significant losses.
Wall Street Split, Management Exits Positions
Analyst sentiment remains fragmented. Roth MKM maintains a buy rating with a $108 price target. Barclays holds an underweight stance at $65. Deutsche Bank downgraded from buy to hold while reducing its target to $106. UBS stays neutral at $80. MarketBeat’s aggregated consensus indicates “Reduce.”
First quarter results disappointed expectations. AST posted a $0.66 per share loss, significantly worse than the anticipated -$0.23 consensus. Revenue of $14.73 million fell short of the $39.01 million forecast. While year-over-year revenue growth reached 1,952%, the substantial miss weighed on sentiment.
Insider selling has been persistent and substantial. Over the past three months, company insiders offloaded more than 3.1 million shares totaling approximately $280.6 million. CFO Andrew Martin Johnson sold 45,809 shares at $93.81 each on June 11, trimming his holdings by 8.34%.
Institutional investors have shown mixed signals. Pictet Asset Management increased its stake by 146.8% in Q1, finishing the quarter holding 79,666 shares valued at $6.6 million. Overall institutional ownership represents 60.95% of shares outstanding.
Jim Cramer offered his perspective this week, characterizing ASTS as “a great speculative stock” and projecting the company could reach profitability within two years. He positioned it as a high-risk, high-reward opportunityāconviction over consensus.
The stock’s 52-week range spans from $36.08 to $133.86. Current technical indicators show the 50-day moving average at $87.38 and the 200-day at $89.44. Analyst consensus forecasts a full-year loss of $1.47 per share.


